Journal: Current Drug Targets - Immune, Endocrine & Metabolic Disorders Volume: 3 Issue: 4 Year: 2003 Page: 291-298 Author(s): James W. Baumgartener
Journal: CNS & Neurological Disorders - Drug Targets Volume: 10 Issue: 3 Year: 2011 Page: 333-339 Author(s): Adrian J. Harwood
Journal: Current Molecular Medicine Volume: 4 Issue: 3 Year: 2004 Page: 277-290 Author(s): Marcus M. Nalaskowski, Georg W. Mayr
Journal: Current Signal Transduction Therapy Volume: 7 Issue: 3 Year: 2012 Page: 289-304 Author(s): Abul Kalam Shamsuddin, Sanchita Bose
Journal: Current Medicinal Chemistry Volume: 10 Issue: 3 Year: 2003 Page: 235-243 Author(s): M. Kakei
Journal: Current Pharmaceutical Design Volume: 12 Issue: 1 Year: 2006 Page: 1531-1541 Author(s): James J. Giles, John G. Bannigan
Journal: Current Medicinal Chemistry Volume: 15 Issue: 2 Year: 2008 Page: 2230-2257 Author(s): Nick J. Wardle, S. W. Annie Bligh, Harry R. Hudson
Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry Volume: 11 Issue: 1 Year: 2011 Page: 48-58 Author(s): Paola Scodelaro Bilbao, Sebastian Katz, Ricardo Boland
Journal: Current Cancer Drug Targets Volume: 13 Issue: 3 Year: 2013 Page: 252-266 Author(s): Richard L. Carpenter, Bing-Hua Jiang
Journal: Current Molecular Medicine Volume: 3 Issue: 5 Year: 2003 Page: 472-482 Author(s): A. J. Harwood
Previous Next